Dartford and Gravesham NHS Trust to pilot ResAppDx

View printer-friendly version Initial pilot in respiratory out-patient clinic before expanding into other clinical areas First pilot of ResAppDx in an NHS trust Data and learnings from the pilot will be pivotal in expanding opportunities within the NHS and Europe more...

Health Teams to launch ResAppDx on aged care telehealth platform

View printer-friendly version Brisbane, Australia, 14 February 2022 — ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, today announced that it has signed...

Cough analysis patent granted in China

View printer-friendly version Brisbane, Australia, 1 February 2022 — ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, today announced that the China...